Send a textHow can the NHS address health inequalities through innovation? How can new health technologies help improve population health? How can Pharma, Medtech and the wider life sciences industry support the NHS with these goals? And what does the NHS’ ambitions in this area mean for your market access strategy?Jon Siddall (Chief Executive of the South West Academic Health Science Network [AHSN]) joins Tom Clarke (Director, Mtech Access) to explore these questions and more.Before joining the South West AHSN as CEO in April 2020, Jon spent 3 years as the director of funding at Guy’s and St Thomas’ Charity, where he led the design and development of the foundation’s £150 million portfolio of urban health programmes focused on some of the biggest health challenges facing cities around the world. During his career Jon has worked with funders, investors and government agencies in the UK, Ireland and New Zealand. His work included 4 years at the South West AHSN, helping to launch the organisation and developing a range of successful innovation programmes.Learn more at: https://mtechaccess.co.uk/health-inequalities-nhs-pharma-medtech/This podcast was originally broadcast as a live webinar on 20th August 2021. Learn more about our NHS insights services at https://mtechaccess.co.uk/uk-nhs-insights/Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related